You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic idiopathic thrombocytopenic purpura

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Thrombocytopenia Trial (VIT D)

Not yet recruiting
  • Immune Thrombocytopenia
  • VIT D
  • (no location specified)
Oct 5, 2023

Idiopathic Thrombocytopenic Purpura Trial in Multiple Locations (R788, Placebo)

Active, not recruiting
  • Idiopathic Thrombocytopenic Purpura
  • Multiple Locations, Japan
    Research Site
Mar 22, 2022

Immune Thrombocytopenic Purpura (ITP) Trial in Worldwide (Immune Globulin Intravenous (Human), 10% Triple Virally Reduced

Completed
  • Immune Thrombocytopenic Purpura (ITP)
  • Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution
  • Brno, Czechia
  • +10 more
Apr 29, 2021

Immune Thrombocytopenia Trial (Herombopag)

Not yet recruiting
  • Immune Thrombocytopenia
  • (no location specified)
Jan 13, 2023

Idiopathic Thrombocytopenic Purpura (ITP) Trial in Taiwan (PG2)

Completed
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Changhua, Taiwan
  • +3 more
Mar 30, 2021

Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • eltrombopag and romiplastim
  • (no location specified)
Nov 16, 2023

Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,

Recruiting
  • Autoimmune Hemolytic Anemia
  • +5 more
  • cytokine essays
  • +6 more
  • Milano, Italy
    Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
Jul 3, 2023

Activity and Safety of Fostamatinib in Consecutive Adult ITP

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • +2 more
  • (no location specified)
Jan 12, 2023

Purpura, Thrombocytopenic, Idiopathic Trial in Germany, United Kingdom, United States (BIVV009 6.5 grams, BIVV009 7.5 grams)

Completed
  • Purpura, Thrombocytopenic, Idiopathic
  • BIVV009 6.5 grams
  • BIVV009 7.5 grams
  • Georgetown, District of Columbia
  • +4 more
Apr 22, 2022

Primary Immune Thrombocytopenia Trial in Shandong (QL0911, Placebo comparator)

Completed
  • Primary Immune Thrombocytopenia
  • Shandong, China
    Qilu Hospital of Shandong University
Nov 20, 2022

Drug Use Investigation for REVOLADE (ITP)

Completed
  • Purpura, Thrombocytopaenic, Idiopathic
  • (no location specified)
Nov 18, 2020

Idiopathic Thrombocytopenic Purpura Trial in Cairo (Eltrombopag, conventional)

Completed
  • Idiopathic Thrombocytopenic Purpura
  • Cairo, Egypt
    Ainshams University , Faculty of medicine , Pediatric Hematology
Oct 26, 2021

Idiopathic Thrombocytopenic Purpura Trial (Placebo, AMG 531)

Completed
Has Results
  • Idiopathic Thrombocytopenic Purpura
  • Placebo
  • AMG 531
  • (no location specified)
Nov 4, 2022

COVID-19 Vaccine and Development of Immune Thrombocytopenic

Recruiting
  • COVID-19 Vaccine
  • covid19 vaccines
  • Assiut, Egypt
    Egypt
Jul 12, 2022

Primary Immune Thrombocytopenia (ITP) Trial (Combination of Rituximab with subcutaneous belimumab, Combination of Rituximab with

Not yet recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Combination of Rituximab with subcutaneous belimumab
  • Combination of Rituximab with subcutaneous placebo
  • (no location specified)
Apr 15, 2022

Purpura, Thrombocytopenic, Idiopathic, Autoimmune Thrombocytopenic Purpura, Purpura, Thrombocytopenic, Autoimmune Trial in

Terminated
  • Purpura, Thrombocytopenic, Idiopathic
  • +2 more
  • veltuzumab
  • Los Angeles, California
  • +7 more
Aug 12, 2021

Immune Thrombocytopenic Purpura Trial in Sohag (serum interleukin 10 level)

Not yet recruiting
  • Immune Thrombocytopenic Purpura
  • serum interleukin 10 level
  • Sohag, Egypt
    Sohag University Hospital
Apr 18, 2023

Idiopathic Thrombocytopenic Purpura Trial in Angers (completion of questionnaire)

Unknown status
  • Idiopathic Thrombocytopenic Purpura
  • completion of questionnaire
  • Angers, France
    CHU d'Angers
Mar 11, 2020

Idiopathic Thrombocytopenic Purpura, Thrombocytopenia, Thrombocytopenic Purpura Trial (Romiplostim)

Completed
Has Results
  • Idiopathic Thrombocytopenic Purpura
  • +2 more
  • Romiplostim
  • (no location specified)
Nov 10, 2022

Primary Immune Thrombocytopenia (ITP) Trial in Tianjin (TPO-RAs, TPO-RAs combining anti-CD 20 mAb)

Not yet recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • TPO-RAs
  • TPO-RAs combining anti-CD 20 monoclonal antibody
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Feb 7, 2023

Chronic Primary Immune Thrombocytopenia (ITP) Trial in China (Qrelabrutinib, Placebo)

Not yet recruiting
  • Chronic Primary Immune Thrombocytopenia (ITP)
  • Bengbu, Anhui, China
  • +13 more
Aug 15, 2023

Idiopathic Thrombocytopenic Purpura Trial in Wuhan, Chengdu, Tianjin (Hetrombopag Olamine, matching )

Completed
  • Idiopathic Thrombocytopenic Purpura
  • Hetrombopag Olamine
  • matching placebo
  • Wuhan, Hubei, China
  • +2 more
Aug 2, 2022

Primary Immune Thrombocytopenia Trial in China (Orelabrutinib( lower dose), Orelabrutinib( higher dose))

Recruiting
  • Primary Immune Thrombocytopenia
  • Orelabrutinib( lower dose)
  • Orelabrutinib( higher dose)
  • HaiKou, Hainan, China
  • +8 more
Jan 10, 2023

Healthy, Primary Immune Thrombocytopenia, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Worldwide

Recruiting
  • Healthy
  • +2 more
  • PF-06755347 intravenous healthy participant
  • +4 more
  • New Haven, Connecticut
  • +5 more
Dec 29, 2022

Immune Markers in Pediatric ITP

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
  • (no location specified)
Oct 17, 2023